MacroGenics | MGNX - Market Capitalization


MacroGenics reported $109.3M in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 371.63B 37.4B Feb/2026
Amgen USD 184.41B 32.48B Feb/2026
AstraZeneca USD 233.07B 17.56B Sep/2025
Biogen USD 20.54B 2.13B Sep/2025
Bristol-Myers Squibb USD 91.8B 2.4B Sep/2025
Daiichi Sankyo JPY 6.34T 62.51B Dec/2025
Eli Lilly USD 1.02T 300.22B Feb/2026
Genmab DKK 80.88B 7.82B Jun/2025
Geron USD 874M 24M Sep/2025
Gilead Sciences USD 137.73B 184M Sep/2025
J&J USD 500.24B 67.44B Dec/2025
MacroGenics USD 114M 8M Feb/2026
Merck USD 293.38B 83.74B Feb/2026
Pfizer USD 147.57B 12.48B Feb/2026
Regeneron Pharmaceuticals USD 81.12B 21.53B Dec/2025
Roche Holding CHF 266.34B 55.46B Dec/2025
Xencor USD 837M 278M Sep/2025